Pulmatrix (PULM) Notes Payables (2014 - 2018)

Pulmatrix (PULM) posted Notes Payables of $1000.0 for Q1 2018, little changed sequentially from $1000.0 in Q4 2017.

Pulmatrix (PULM) Notes Payables (2014 - 2018) Analysis & Trends

Pulmatrix has reported Notes Payables for 3 years, with the latest figure at $1000.0 in Q1 2018.

Quarterly Notes Payables changed N/A year-over-year to $1000.0 in Q1 2018, while the trailing twelve-month figure through Mar 2018 was $1000.0 (changed N/A YoY) and the FY2017 annual result came in at $1000.0, changed N/A from the prior year.
Notes Payables held at $1000.0 in Q1 2018 per PULM's latest filing, from $1000.0 in the prior quarter.
Over five years, Notes Payables peaked at $39.7 million in Q4 2014 and troughed at $1000.0 in Q4 2017.
A 3-year average of $13.2 million and a median of $1000.0 in 2017 frame the typical range for Notes Payables.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	140.14 Bn	132.29 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	87.02 Bn	79.03 Bn	3.93 Bn
3	Argenx Se	65.30 Bn	60.12 Bn	1.37 Bn
4	Moderna	60.84 Bn	55.70 Bn	52.00 Mn
5	BeOne Medicines	42.15 Bn	37.06 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.49 Bn	28.18 Bn	992.69 Mn
7	BioNTech SE	28.78 Bn	10.38 Bn	668.28 Mn
8	Insmed	27.55 Bn	26.39 Bn	358.27 Mn
9	Royalty Pharma	27.14 Bn	26.31 Bn	-
10	Pulmatrix	5.55 Mn	5.55 Mn	-

Download Data